Research and Markets: Onartuzumab (Non-Small Cell Lung Cancer) – Forecast … – The Herald | HeraldOnline.com

by lowes1 on October 10, 2013

Research and Markets: Onartuzumab (Non-Small Cell Lung Cancer) – Forecast
The Herald | HeraldOnline.com
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients 

and more »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: